60 Degrees Pharmaceuticals Inc. (SXTP)
(Delayed Data from NSDQ)
$1.36 USD
-0.10 (-6.85%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.39 +0.03 (2.21%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SXTP 1.36 -0.10(-6.85%)
Will SXTP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SXTP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SXTP
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates
SXTP: What are Zacks experts saying now?
Zacks Private Portfolio Services
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates
OptiNose (OPTN) Reports Break-Even Earnings for Q3
Other News for SXTP
Fell Below 20 Day Moving Average appears for SXTP after 6.85% move
SXTP forms 20 Day Moving Average Support on September 19
Directional Movement Crossover Bullish appears for SXTP after 0.0% move
SXTP forms 20 Day Moving Average Support on September 16
Is SXTP about to break its pattern? Narrow Range Bar shows up after slipping 2.14%